Research and Evidence
QEEG and PBM Case Studies • Publications • Links
The science behind iMediSync
Rapid advances in Artificial Intelligence continue to help improve brain measurement technology. Development and clinical trials of the iMediSync Medical Series are currently ongoing, in collaboration universities and hospitals in South Korea. Diagnosis and PBM treatment trials in areas like Alzheimer’s, coma recovery, stroke cognitive impairment, Parkinson’s, depression and brain age are in their final stage, and will become available to clinicians in Australasia in 2022. ADHD, PTSD and TBI are areas currently under earlier research stages.
QEEG Case Study Sample: MCI
PBM Case Study Sample: Depression